Table 2.
Comparison of the general characteristics of the three groups of WCE.
WCE2.5-97.5 (n = 2874) | WCE2.5 (n = 41) | WCE97.5 (n = 57) | p a | |
---|---|---|---|---|
Age (years) | 56 (49, 69) | 56 (49, 68) | 58 (46, 69) | 0.995 |
Gender (male, n, %) | 1302 (45.3) | 18 (43.9) | 28 (49.1) | 0.833 |
BMI (kg/m2) | 25.2 (23.1, 27.5) | 24.5 (21.5, 27.9) | 25.4 (22.5, 27.5) | 0.547 |
SBP (mmHg) | 131 (119, 144) | 130 (115, 148) | 136 (126, 150) | 0.035 |
DBP (mmHg) | 79 (71, 85) | 81 (71, 87) | 79 (70, 87) | 0.974 |
HR (bpm) | 76 (70, 84) | 76 (67, 84) | 76 (72, 81) | 0.957 |
cIMT (mm) | 0.63 (0.49, 0.75) | 0.61 (0.45, 0.69) | 0.61 (0.46, 0.72) | 0.221 |
Ba-PWV (cm/s) | 1602 (1360, 1892) | 1814 (1393, 2040) | 1702 (1430, 2037) | 0.057 |
TC (mmol/l) | 5.10 (4.50, 5.78) | 5.09 (4.38, 5.83) | 5.30 (4.77, 5.90) | 0.348 |
TG (mmol/l) | 1.31 (0.96, 1.92) | 1.53 (1.06, 2.23) | 1.41 (1.02, 1.94) | 0.272 |
Smoking (n, %) | 722 (25.1) | 13 (31.7) | 19 (33.3) | 0.238 |
Hypertension (n, %) | 1368 (47.6) | 24 (58.5) | 33 (57.9) | 0.120 |
Antihypertensive drug usage (n, %) | 830 (29.0) | 14 (34.1) | 17 (29.8) | 0.632 |
CKD (n, %) | 141 (4.9) | 1 (2.4) | 1 (1.8) | 0.420 |
MI (n, %) | 110 (3.8) | 3 (7.3) | 2 (3.5) | 0.511 |
Diabetes (n, %) | 318 (11.1) | 9 (22.0) | 8 (14.0) | 0.073 |
Stroke (n, %) | 198 (6.9) | 7 (17.1) | 3 (5.3) | 0.035 |
Carotid plaque (n, %) | 1477 (51.6) | 22 (53.7) | 19 (33.3) | 0.023 |
a P for comparison among the three WCE groups.